Holen Sie sich die Stockscreener-App
2.72
6.21%
-0.18
Handel nachbörslich:
2.73
0.010
+0.37%
Schlusskurs vom Vortag:
$2.90
Offen:
$2.86
24-Stunden-Volumen:
603.97K
Relative Volume:
0.26
Marktkapitalisierung:
$8.42M
Einnahmen:
$9.37M
Nettoeinkommen (Verlust:
$-8.45M
KGV:
-3.358
EPS:
-0.81
Netto-Cashflow:
$-7.27M
1W Leistung:
+4.21%
1M Leistung:
-64.51%
6M Leistung:
-83.81%
1J Leistung:
-95.30%
1-Tages-Spanne:
$2.6501
$3.05
1-Wochen-Bereich:
$2.3401
$3.65
52-Wochen-Spanne:
$2.3401
$67.12
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Firmenname
Bioaffinity Technologies Inc
Sektor
Branche
Telefon
210-698-5334
Adresse
3300 NACOGDOCHES ROAD, SAN ANTONIO
Vergleichen Sie BIAF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
2.72 | 8.42M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten
Key resistance and support levels for bioAffinity Technologies Inc. Equity WarrantTake Profit & Fast Entry High Yield Tips - newser.com
Biotech Stocks To Follow TodayOctober 8th - MarketBeat
Is bioAffinity Technologies Inc. building a consolidation base2025 Fundamental Recap & Free Community Consensus Stock Picks - newser.com
How to track smart money flows in bioAffinity Technologies Inc. Equity WarrantVolume Spike & Reliable Entry Point Alerts - newser.com
Visual trend scoring systems applied to bioAffinity Technologies Inc. Equity WarrantJuly 2025 Volume & Trade Opportunity Analysis - newser.com
Is bioAffinity Technologies Inc. Equity Warrant stock attractive for retirement portfoliosJuly 2025 Technicals & Safe Capital Growth Plans - newser.com
Developing predictive dashboards with bioAffinity Technologies Inc. data2025 Analyst Calls & Weekly High Momentum Picks - newser.com
Will bioAffinity Technologies Inc. stock maintain momentum in 2025July 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
bioAffinity Technologies Announces $1.8M Direct Offering - MSN
bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Comm - PharmiWeb.com
$1.8M Registered Direct Offering: bioAffinity Closes 720K Shares to Fund CyPath Lung Sales - Stock Titan
bioAffinity Technologies closes $1.8 million registered direct offering - Investing.com India
BioAffinity Technologies Closes $1.8 Million Registered Direct Offering - MarketScreener
bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules - Business Wire
What analysts say about bioAffinity Technologies Inc stockLong-Term Growth Stocks & Affordable Portfolio Growth - earlytimes.in
Can trapped investors hope for a rebound in bioAffinity Technologies Inc.2025 Buyback Activity & Reliable Entry Point Alerts - newser.com
Exit strategy if you’re trapped in bioAffinity Technologies Inc.Gap Up & Low Risk Entry Point Guides - newser.com
Does bioAffinity Technologies Inc. Equity Warrant fit your quant trading modelWeekly Trend Recap & Stock Portfolio Risk Control - newser.com
How to build a dashboard for bioAffinity Technologies Inc. stockTrade Risk Report & Long-Term Safe Return Strategies - newser.com
Signal strength of bioAffinity Technologies Inc. stock in tech scannersWeekly Trend Summary & AI Enhanced Market Trend Forecasts - newser.com
Why bioAffinity Technologies Inc. stock appeals to analystsQuarterly Profit Report & Daily Growth Stock Tips - newser.com
How to read the order book for bioAffinity Technologies Inc.July 2025 Levels & Low Drawdown Momentum Ideas - newser.com
BioAffinity Technologies Launches $1.8 Million Registered Direct Offering - MarketScreener
bioAffinity Technologies raises $1.8 million in registered direct offering By Investing.com - Investing.com Nigeria
WallachBeth Capital announces bioaffinity technologies - MarketScreener
bioAffinity Technologies raises $1.8 million in registered direct offering - Investing.com India
$1.8M Offering: bioAffinity to Sell 720,000 Shares at $2.50 to Fund CyPath® Lung Sales - Stock Titan
bioAffinity Technologies raises $1.8 million in direct offering - Investing.com
BioAffinity Technologies announces $1.8M registered direct offering - TipRanks
bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules - The Joplin Globe
$1.8M registered direct raise — bioAffinity to sell 720K shares to fund CyPath Lung sales - Stock Titan
BioAffinity Technologies Stock Surges: What’s Next? - StocksToTrade
What's Driving bioAffinity Technologies' Big Pre-Market Surge? - Benzinga
bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025 - BioSpace
bioAffinity Technologies reports 95% quarterly sales growth for lung test By Investing.com - Investing.com Canada
bioAffinity Technologies Reports 95% Sales Surge in Q3 2025 - TipRanks
BioAffinity's lung cancer test sales soar 95% as veterans' hospitals drive adoption - The Business Journals
BioAffinity Technologies reports record growth for CyPath Lung diagnostic test - TipRanks
bioAffinity Technologies reports 95% quarterly sales growth for lung test - Investing.com India
bioAffinity Technologies Inc Stock Analysis and ForecastSupport and Resistance Levels & Outstanding Portfolio Tips - earlytimes.in
Published on: 2025-10-06 06:37:07 - newser.com
Predicting bioAffinity Technologies Inc. Equity Warrant trend using moving averagesJuly 2025 Review & Weekly High Potential Stock Alerts - newser.com
Applying chart zones and confluence areas to bioAffinity Technologies Inc.Short Setup & Capital Efficient Trade Techniques - newser.com
Can swing trading help recover from bioAffinity Technologies Inc. Equity Warrant losses2025 Volatility Report & Safe Capital Growth Stock Tips - newser.com
News impact scoring models applied to bioAffinity Technologies Inc.Market Activity Summary & Technical Pattern Based Buy Signals - newser.com
Using data tools to time your bioAffinity Technologies Inc. exitTrade Volume Report & Weekly Stock Breakout Alerts - newser.com
Analyzing bioAffinity Technologies Inc. with multi timeframe chartsTrade Exit Summary & Weekly Stock Breakout Alerts - newser.com
Is bioAffinity Technologies Inc. stock a buy on dipsTrade Risk Report & AI Based Buy and Sell Signals - newser.com
bioAffinity Technologies Stock Price, Quotes and Forecasts | NASDAQ:BIAF - Benzinga
Will bioAffinity Technologies Inc. Equity Warrant stock remain a Wall Street favoriteEntry Point & High Accuracy Swing Trade Signals - newser.com
Why bioAffinity Technologies Inc. stock is in analyst buy zoneEntry Point & Low Risk Entry Point Tips - newser.com
Finanzdaten der Bioaffinity Technologies Inc-Aktie (BIAF)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.17%
2.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):